Hemodynamic and Perfusion Response to Drotrecogin Alfa (Activated) in Patients With Septic Shock
Status:
Completed
Trial end date:
2007-11-01
Target enrollment:
Participant gender:
Summary
The study will evaluate the vasopressor requirement, hemodynamic response and measures of
tissue perfusion in patients with septic shock receiving an infusion of drotrecogin alfa
(activated) compared to patients not receiving drotrecogin alfa (activated).